Pan-RAS inhibitor daraxonrasib doubles survival in pancreatic cancer trial
A new review details how the pan-RAS inhibitor daraxonrasib doubled overall survival in a phase III pancreatic cancer trial and ...
A new review details how the pan-RAS inhibitor daraxonrasib doubled overall survival in a phase III pancreatic cancer trial and ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine